Drug name - Abilify Maintena Kit

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8993761 OTSUKA PHARM CO LTD Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Sep, 2022

(a day ago)

US8399469 OTSUKA PHARM CO LTD Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Jun, 2025

(2 years from now)

CN1699346A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Dec, 2007

(14 years ago)

CN101423493A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug And Processes For Preparation Thereof
Jun, 2012

(10 years ago)

CN101574347B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101434574A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101423492A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101579344A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101579343B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101579344B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101579343A OTSUKA PHARM CO LTD Low-Hygroscopicity Aripiprazole Medicine And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101434573A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101574347A OTSUKA PHARM CO LTD Low Hygroscopic Forms Of Aripiprazole And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101423492B OTSUKA PHARM CO LTD Aripiprazole Anhydride Crystal, Method For Producing The Same And Medicinal Preparation Containing The Same
Sep, 2019

(3 years ago)

CN103755632B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101434574B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101574348A OTSUKA PHARM CO LTD Aripiprazole With Low Hygroscopicity And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101434573B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN103755632A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101574348B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN1817882A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Sep, 2022

(a day ago)

CN103288727B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

CN103288727A OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

CN1817882B OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1330249A1 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Dec, 2020

(1 year, 9 months ago)

EP1330249B1 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Dec, 2020

(1 year, 9 months ago)

EP1419776A2 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1925308A1 OTSUKA PHARM CO LTD Pharmaceutical Solid Oral Aripiprazole Preparation And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357B1 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927355A1 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole (Crystal F) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776B1 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1925308B1 OTSUKA PHARM CO LTD Pharmaceutical Solid Oral Aripiprazole Preparation And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776B2 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357A3 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927355B1 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole (Crystal F) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927356A1 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole (Crystal D) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A9 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357A2 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927356B1 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole (Crystal D) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A3 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A8 OTSUKA PHARM CO LTD Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8759351 OTSUKA PHARM CO LTD Methods for administering aripiprazole Aug, 2023

(10 months from now)

US8338428 OTSUKA PHARM CO LTD Methods for administering aripiprazole Aug, 2023

(10 months from now)

US8030313 OTSUKA PHARM CO LTD Controlled release sterile injectable aripiprazole formulation and method Oct, 2024

(2 years from now)

US7807680 OTSUKA PHARM CO LTD Controlled release sterile injectable aripiprazole formulation and method Oct, 2024

(2 years from now)

US8722679 OTSUKA PHARM CO LTD Controlled release sterile injectable aripiprazole formulation and method Oct, 2024

(2 years from now)

US8338427 OTSUKA PHARM CO LTD Methods for administering aripiprazole Mar, 2025

(2 years from now)

US11154553 OTSUKA PHARM CO LTD Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function Sep, 2033

(11 years from now)

US10980803 OTSUKA PHARM CO LTD Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function Sep, 2033

(11 years from now)

US10525057 OTSUKA PHARM CO LTD Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function Mar, 2034

(11 years from now)

Drugs and Companies using ARIPIPRAZOLE ingredient

Treatment: Use of aripiprazole in extended release injectable suspension; use of aripiprazole in extended release injectable suspension in treating acute episodes of schizophrenia; Use of aripiprazole in extended release injectable suspension in treating acute episodes of schizophrenia; treatment of schizophrenia; Treatment of schizophrenia; treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia; Treatment of schizophrenia; use of aripiprazole in extended release injectable suspension in treating acute episodes of schizophrenia; Treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia; treatment of schizophrenia; maintenance monotherapy treatment of bipolar i disorder; Maintenance monotherapy treatment of bipolar 1 disorder; treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia; treatment of schizophrenia

Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
300MG/VIAL FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
300MG FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
400MG/VIAL FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
400MG FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription

availability in other generic markets.

Click on the highlighted region to filter.